New Releases from NCBI BookshelfEribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen.Eribulin for treating locally advanced or metastatic breast cancer after 1 chemotherapy regimen.
Post Content
Uncategorized
Uncategorized
New Releases from NCBI BookshelfOdevixibat (Bylvay): Indication: For the treatment of cholestatic pruritus in patients aged 12 months and older with Alagille syndrome (ALGS): Reimbursement Recommendation [Internet].Odevixibat (Bylvay): Indication: For the treatment of cholestatic pruritus in patients aged 12 months and older with Alagille syndrome (ALGS): Reimbursement Recommendation [Internet].
Canada’s Drug Agency (CDA-AMC) recommends that Bylvay be reimbursed by public drug plans for the treatment of cholestatic pruritus in
Uncategorized
New Releases from NCBI BookshelfTrabectedin: Therapeutic area: Soft tissue and uterine leiomyosarcoma: Reimbursement Review [Internet].Trabectedin: Therapeutic area: Soft tissue and uterine leiomyosarcoma: Reimbursement Review [Internet].
Soft tissue sarcomas are a heterogeneous group of rare tumours in muscle, adipose, fibrous, cartilage, nerve, and vascular tissue. Leiomyosarcoma
